Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine

Neil Brickel1 Neurosciences Therapy Area Unit, GlaxoSmithKline, Uxbridge, Middlesex, UKCorrespondence[email protected]

Sarah DeRossett2 Neurosciences Therapy Area Unit, GlaxoSmithKline, Research Triangle Park, NC, USA

Mauro Buraglio3 Neurosciences Therapy Area Unit, GlaxoSmithKline, Stevenage, Hertfordshire, UK

Christopher Evans4 Bioanalytical Science and Toxicokinetics, PTS-DMPK, GlaxoSmithKline, King of Prussia, PA, USA

Siôn Jones5 Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UK

Pages 207-213 | Published online: 07 May 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

RundfeldtCNetzerRThe novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunitsNeurosci Lett2000282737610713399
PubMed Web of Science ®Google Scholar
FerronGMPaulJFruncilloRMultiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteersJ Clin Pharmacol20024217518211831540
PubMed Web of Science ®Google Scholar
BorlakJGasparicALocherMSchupkeHHermannRN-Glucuronidation of the antiepileptic drug retigabine: results from studies with human volunteers, heterologously expressed human UGTs, human liver, kidney, and liver microsomal membranes of Crigler-Najjar type IIMetabolism20065571172116713428
PubMed Web of Science ®Google Scholar
GlaxoSmithKlinePotiga™ Prescribing Information Available from: http://us.gsk.com/products/assets/us_potiga.pdfAccessed December 6, 2012
Google Scholar
PorterRJPartiotASachdeoRNohriaVAlvesWMRandomized, multicenter, dose-ranging trial of retigabine for partial-onset seizuresNeurology2007681197120417420403
PubMed Web of Science ®Google Scholar
BrodieMJLercheHGil-NagelAEfficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsyNeurology2010751817182420944074
PubMed Web of Science ®Google Scholar
FrenchJAAbou-KhalilBWLeroyRFRandomized double-blind placebo-controlled trial of ezogabine (retigabine) in partial epilepsyNeurology2011761555156321451152
PubMed Web of Science ®Google Scholar
StrengTCristophTAnderssonKEUrodynamic effects of the K+ channel (KCNQ) opener retigabine in freely moving conscious ratsJ Urol20041722054205815540788
PubMed Web of Science ®Google Scholar
GreenwoodIAOhyaSNew tricks for old dogs. KCNQ expression and role in smooth muscleBr J Pharmacol20091561196120319751313
PubMed Web of Science ®Google Scholar
RodeFSvaloJSheykhzadeMRonnLCFunctional effects of the KCNQ modulators retigabine and XE991 in the rat urinary bladderEur J Pharmacol201063812112720385123
PubMed Web of Science ®Google Scholar
BrickelNGandhiPVanLandinghamKHamondJDeRossettSThe urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channelsEpilepsia20125360661222428574
PubMed Web of Science ®Google Scholar
FogazziGBCrystalluria: a neglected aspect of urinary sediment analysisNephrol Dial Transplant1996113793878671802
PubMed Web of Science ®Google Scholar
SimervilleJAMaxtedWCPahiraJJUrinalysis: a comprehensive reviewAm Fam Physician2005711153116215791892
PubMed Web of Science ®Google Scholar
Gil-NagelABrodieMJLeroyRSafety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: interim results from two ongoing open-label studiesEpilepsy Res201210211712122771137
PubMed Web of Science ®Google Scholar
NICE 2008Chronic kidney diseaseEarly identification and management of chronic kidney disease in adults in primary and secondary care Available from: http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdfAccessed January 2, 2013
Google Scholar
SaudanPJBrownMAFarrellTShawLImproved methods of assessing proteinuria in hypertensive pregnancyBr J Obstet Gynaecol1997104115911649332994
PubMedGoogle Scholar
KylePMFielderJNPullarBHorwoodLJMooreMPComparison of methods to identify significant proteinuria in pregnancy in the outpatient settingBJOG200811552352718201282
PubMed Web of Science ®Google Scholar
National Collaborating Centre for Chronic ConditionsChronic Kidney Disease: National Clinical Guideline for Early Identification and Management of Adults in Primary and Secondary CareLondon, UKRoyal College of Physicians2008
Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Investigation of the impact of urine handling procedures on interpretation of urinalysis findings and product safety in subjects treated with ezogabine

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date